2005, Number 3
<< Back Next >>
Med Sur 2005; 12 (3)
Hepatitis because of Epstein-Barr virus:
A case report
Hernández-Estrada S, Aguilar DC, Lizardi CJ
Language: Spanish
References: 12
Page: 177-179
PDF size: 47.79 Kb.
ABSTRACT
Epstein-Barr Virus is the causative agent of infectious mononucleosis. The common manifestations are fever, pharyngitis, limphadenopathy, hepatosplenomegaly and atypical lymphocytosis. Infectious mononucleosis is caused by an intense cytotoxic T lymphocyte response to eliminate EBV-infected B cells. Rarely, it results in hepatic injury with severe jaundice. The histological features are characterized by a mild increase in portal inflammation that consists of lymphocytes. In this case Epstein-Barr Virus did not infect hepatocytes, but infected T cells.
REFERENCES
Godshall A. Infectious mononucleosis: Complexities of a common syndrome. Posgrad Med 2000; 107: 175.
Crawford DH. Epstein-Barr Virus. Recent Advances. The Lancet Infect Dis 2003; 3: 131-40.
Borer A. Clinical features and costs of care for hospitalized adults with primary EBV infection. Am J Med 1999; 107: 144.
Kinoshita E. Persistent hepatitis associated with chronic active Epstein-Barr Virus Infection. Pediatr Infect Dis 2004; 23: 74-6.
Hara S. Association of virus infected-T cell in severe Hepatitis caused by primary Epstein-Barr virus Infection. Jour of Clin Virol 2005: 1-7.
Feranchak A. Fulminant Epstein-Barr Viral Hepatitis. Orthotopic liver transplantation and review of the literature. Liver Trans 4, 1998: 469-76.
Balfour H. A Prospective Clinical Study of Epstein-Barr Virus and Host Interactions during Acute Infectious Mononucleosis. 2005; 192: 1502-12.
Kimura H. Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus Infection. J Infect Dis 2005; 191: 531-9.
Woodberry,T. Differential Targeting and Shifts in the Immunodominance of Epstein-Barr Virus Specific CD8 and CD4 Cell responses during Acute Persistent Infection. 2005; 192: 1513-24.
Kimura H. Severe Hepatitis caused by Epstein-Barr Virus without infection of hepatocytes. Hum Pathol 2001; 32: 757-62.
Temak G. Epstein-Barr Virus Reactivation. Lancet Infect Dis 2003; 3: 271.
Mendez-Sanchez N, Aguilar C. Hepatic manifestations of Epstein-Barr viral infection. Ann Hepatol 2005; 4(3): 205-9.